https://www.fool.com/investing/2024/03/29/software-stock-posts-jump-profitability-uipath/?source=iedfolrf0000001
Mar 29, 2024 - UiPath management underpromised and the company overdelivered once again.
0
fool:-5500650775588090441
0
https://www.zacks.com/stock/news/2248661/post-holdings-post-gains-on-effective-pricing-acquisitions?cid=CS-ZC-FT-analyst_blog|rank_focused-2248661
Apr 01, 2024 - Post Holdings (POST) intends to strengthen its business on the back of strategic acquisitions. The company is reaping benefits from a favorable pricing environment.
zc:3860377903374584129
0
https://www.zacks.com/stock/news/2248480/acuity-brands-ayi-to-post-q2-earnings-factors-to-consider?cid=CS-ZC-FT-analyst_blog|earnings_preview-2248480
Apr 01, 2024 - Acuity Brands' (AYI) fiscal second-quarter performance is likely to have ailed from softness in the ABL segment amid cost improvement.
zc:-4538404419801917208
0
https://seekingalpha.com/news/4086511-hondas-north-american-unit-posts-118-rise-in-sales-in-march?source=feed_tag_japan
Apr 02, 2024 - American Honda, the North American subsidiary of the Japanese carmaker, reported an 11.8% increase in sales in March, with the Honda brand experiencing its...
0
sa:-6958989352919451145
0
https://www.zacks.com/stock/news/2250435/airline-stock-roundup-azul-posts-loss-in-q4-algt-s-february-traffic-improves?cid=CS-ZC-FT-analyst_blog|stock_roundup-2250435
Apr 04, 2024 - JetBlue (JBLU) expands its international presence. Alaska Air (ALK) expects its long-term profitability to be hurt due to Boeing's woes.
zc:9066031380984675996
0
https://www.zacks.com/stock/news/2252013/fastenal-fast-to-post-q1-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2252013
Apr 08, 2024 - Fastenal's (FAST) Q1 results are likely to reflect manufacturing growth, albeit at a slow pace, with a strong digital strategy and a balanced onsite/offsite mix. Yet, slowing industrial markets are a concern.
zc:-9078637482007820009
0
https://seekingalpha.com/news/4088165-alkermes-stock-gains-sleeping-disorder-drug?source=feed_sector_healthcare
Apr 09, 2024 - Alkermes (ALKS) stock gains on positive Phase 1b trial results for the company's oral sleeping disorder therapy, ALKS 2680. Read more here.
0
sa:-1337001873957017049
0
https://www.zacks.com/stock/news/2253877/alx-oncology-alxo-posts-upbeat-results-from-lymphoma-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2253877
Apr 11, 2024 - ALX Oncology (ALXO) announces positive results from an early to mid-stage study of an investigational combination regimen to treat indolent and aggressive R/R B-NHL.
zc:-3943974083839332350
0
https://www.zacks.com/stock/news/2254707/equifax-efx-to-post-q1-earnings-what-s-in-the-offing?cid=CS-ZC-FT-analyst_blog|earnings_preview-2254707
Apr 12, 2024 - Equifax's (EFX) first-quarter 2024 revenues are likely to have benefited from strong market penetration and growth in Latin America.
zc:6456388096799952852
0
https://seekingalpha.com/news/4089597-bofa-picks-ppg-industries-netflix-and-united-airlines-for-options-opportunity-ahead-of-earnings?source=feed_sector_healthcare
Apr 15, 2024 - This article discusses a recent report from BoFA Securities on US equity options and positioning for potential earnings surprises.
0
sa:4654003398674251359
0